It was a big shock this week for many in the industry to learn of the impending closure of the Pfizer site in Kent with the loss of 2,400 jobs.
It has been stated that the Science Minister, David Willets has pledged to look at the possibilities of creating a new science park on the site. This would hopefully utilise some of the highly skilled staff that presently work for Pfizer on the site.
The full reason behind the closure seems unclear and discussions about whether Pharma companies see the UK as the right place for R&D will continue.
Overall the Pharma industry has been hit hard by the ‘crunch’ but it appears that it is not the same across the board and other large UK based R&D Pharma companies are looking forward with cautious optimism. As always discovering and developing the right product is, of course, paramount.
FoodWorld 